FER1L5

FER1L5 is a multi-C2-domain ferlin protein that functions as a Ca2+-sensing mediator of regulated membrane fusion and repair (PMID:33182221, PMID:36696506). In myoblasts it resides on low-density vesicles and concentrates at the apposed membranes of fusing cells, where it is required for myoblast fusion and plasma-membrane repair (PMID:33182221). Its delivery to the plasma membrane depends on the endocytic recycling machinery: FER1L5 binds the ATPases EHD1 and EHD2 directly through its second C2 domain (C2B), and loss of EHD1 or EHD2 mislocalizes the protein and blocks fusion (PMID:21177873, PMID:24440153). FER1L5 distributes between the plasma membrane and Rab7-positive late endosomes, distinguishing it from trans-Golgi/recycling-endosome-localized ferlins (PMID:26707827). Its most sharply defined physiological role is in spermatozoa, where FER1L5 is essential for the Ca2+-activated acrosome reaction: Fer1l5 mutant males are infertile and their sperm fail to undergo the acrosome reaction even when intracellular Ca2+ is forced upward by ionophore, placing FER1L5 genetically downstream of Ca2+ entry as a required effector of this exocytotic event (PMID:36696506).

1. 2010 Medium

   Established how FER1L5 is delivered to the plasma membrane by identifying a direct molecular link between the protein and the endocytic recycling machinery and mapping the responsible domain.

   Evidence Pulldown binding assay with C2-domain constructs and localization in myoblasts, plus EHD1/EHD2 knockdown with fusion readout

   PMID:21177873

   Open questions at the time

   • Single lab; reciprocal validation of the EHD interaction not established
   • Whether C2B-EHD binding is Ca2+-regulated is unaddressed
   • Structural basis of the C2B-EHD interface unknown
2. 2014 Medium

   Confirmed in vivo that EHD1 governs FER1L5 subcellular targeting, moving the recycling-dependent localization model from knockdown into a genetic-null context.

   Evidence EHD1-null mouse myoblasts with immunofluorescence localization of Fer1L5

   PMID:24440153

   Open questions at the time

   • Functional consequence of mislocalization for muscle in the animal not quantified
   • Does not separate EHD1 direct vs. indirect effects
3. 2016 Medium

   Defined FER1L5's steady-state compartments, classifying it as a type-I ferlin enriched at the plasma membrane and Rab7+ late endosomes rather than the trans-Golgi/recycling-endosome pool of other ferlins.

   Evidence 3D-SIM super-resolution microscopy and Rab7/Rab11 endosomal transit assays

   PMID:26707827

   Open questions at the time

   • FER1L5 data embedded in broader family survey
   • Functional role of the late-endosomal pool not tested
4. 2020 Medium

   Linked FER1L5 localization to function by showing it accumulates at myoblast fusion sites on low-density vesicles and is required for both fusion and membrane repair.

   Evidence Biochemical fractionation, confocal immunolabeling, laser-wounding repair assay, and inhibitory antibody treatment in C2C12 cells

   PMID:33182221

   Open questions at the time

   • Antibody inhibition not corroborated by genetic loss-of-function in muscle
   • Ca2+-dependence of the vesicle accumulation not directly tested
5. 2023 High

   Identified the essential physiological role of FER1L5 as a required effector of the Ca2+-triggered acrosome reaction acting downstream of Ca2+ influx, explaining male infertility in its absence.

   Evidence Fer1l5 mutant mouse with fertility, sperm migration, and Ca2+-ionophore acrosome-reaction assays

   PMID:36696506

   Open questions at the time

   • Molecular partners of FER1L5 in the acrosomal fusion machinery not identified
   • Whether C2 domains directly sense the Ca2+ signal during the reaction untested
   • Connection between sperm role and muscle fusion role mechanistically unresolved

• How FER1L5's C2 domains transduce Ca2+ signals into membrane fusion, and which SNARE or fusion-machinery partners it engages during the acrosome reaction and myoblast fusion, remains unresolved.
• No identified fusion-machinery partners
• No experimental validation of Ca2+ binding by specific C2 domains
• No structural model of the membrane-engaged state